Australia's most trusted
source of pharma news
Wednesday, 16 October 2024
Posted 15 October 2024 AM
Ten pharmas are in a strong position to secure government subsidy for their drugs next month, a Pharma in Focus analysis shows.
These companies each had one submission recommended by the PBAC over the past three years that has since reached the last stage before PBS listing occurs known as the 'government processes' stage. However, most of the drugs were recommended at the July 2024 meeting.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.